Skip to main content

The Mass Casualty Commission is an independent public inquiry created to examine the Nova Scotia Mass Casualty of April 18-19, 2020. Its aim is to provide meaningful recommendations to help protect Canadians in the future. The Commission is mandated to report its findings and make recommendations by November 2022.

The following page provides a list of key resources about the Commission and will be updated frequently.

For media enquiries, or to be added to the media list to receive updates, please contact: media@masscasualtycommission.ca

News Releases

The following news releases have been issued by the Mass Casualty Commission:

Photo Gallery

The following photos, provided by the Mass Casualty Commission, are for use by media and are not for commercial or personal reuse. Images are not to be altered. Questions about the use of these photos can be sent to: media@masscasualtycommission.ca.

Orders in Council

The details of the mandate are written in official documents known as Orders in Council (OICs) which provide the guidelines and boundaries for the Mass Casualty Commission to proceed with its work.

Documents

Order in Council: Government of Canada pdf

Documents

Order in Council: Government of Nova Scotia pdf

More Information

FAQs can be found here.

For social media platform information see here.

Official documents can be found here

Some of the information within this website may be disturbing or upsetting for some visitors. This website deals with information about events that include gun and other violence, including gender-based violence and intimate partner violence. If you need to leave at any point, there is a “quick exit” button at the top of the website. This website also includes some suggested resources, should you be in need of support.

This website uses cookies
We use cookies to help improve your experience while using this website. By continuing to use this site you are agreeing to this use of cookies. Read more about cookies and other information in our Privacy Policy.